<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35339673</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 syndrome and humoral response association after 1&#xa0;year in vaccinated and unvaccinated patients.</ArticleTitle><Pagination><StartPage>1140</StartPage><EndPage>1148</EndPage><MedlinePgn>1140-1148</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2022.03.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(22)00155-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to describe the impact of vaccination and the role of humoral responses on post-COVID-19 syndrome 1&#xa0;year after the onset of SARS coronavirus type 2 (CoV-2).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective study was conducted through interviews to investigate post-COVID-19 syndrome 6 and 12&#xa0;months after disease onset in all adult in- and outpatients with COVID-19 at Udine Hospital (March-May 2020). Vaccination status and two different serological assays to distinguish between response to vaccination (receptor-binding domain (RBD) SARS-CoV-2 IgG) and/or natural infection (non-RBD-SARS-CoV-2 IgG) were also assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 479 patients (52.6% female; mean age: 53&#xa0;years) were interviewed 13.5&#xa0;months (standard deviation: 0.6&#xa0;months) after acute infection. Post-COVID-19 syndrome was observed in 47.2% of patients (n&#xa0;=&#xa0;226) after 1&#xa0;year. There were no significant differences in the worsening of post-COVID-19 symptoms (22.7% vs. 15.8%; p&#xa0;=&#xa0;0.209) among vaccinated (n&#xa0;=&#xa0;132) and unvaccinated (n&#xa0;=&#xa0;347) patients. The presence of non-RBD SARS-CoV-2 IgG induced by natural infection showed a significant association with post-COVID-19 syndrome (OR: 1.35; 95% CI, 1.11-1.64; p&#xa0;=&#xa0;0.003), and median non-RBD SARS-CoV-2 IgG titres were significantly higher in long haulers than in patients without symptoms (22 kAU/L (interquartile range, 9.7-37.2 kAU/L) vs. 14.1 kAU/L (interquartile range, 5.4-31.3 kAU/L); p&#xa0;=&#xa0;0.009) after 1&#xa0;year. In contrast, the presence of RBD SARS-CoV-2 IgG was not associated with the occurrence of post-COVID-19 syndrome (&gt;2500 U/mL vs. 0.9-2500 U/mL; OR: 1.36; 95% CI, 0.62-3.00; p&#xa0;=&#xa0;0.441), and RBD SARS-CoV-2 IgG titres were similar in long haulers as in patients without symptoms (50% values&#xa0;&gt;&#xa0;2500 U/mL vs. 55.6% values&#xa0;&gt;&#xa0;2500 U/mL; p&#xa0;=&#xa0;0.451).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The SARS-CoV-2 vaccination is not associated with the emergence of post-COVID-19 symptoms more than 1&#xa0;year after acute infection. The persistence of high serological titre response induced by natural infection, but not vaccination, may play a role in long-haul COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peghin</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy. Electronic address: maddalena.peghin@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Martino</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Medical Statistics, Department of Medicine, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palese</LastName><ForeName>Alvisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Nursing, Department of Medical Sciences, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerussi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bontempo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graziano</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visintini</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Nursing, Department of Medical Sciences, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Elia</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellai</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrella</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabris</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pathology, Department of Laboratory Medicine, Azienda Sanitaria Universitaria Friuli Centrale and University of Udine, Department of Medicine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curcio</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pathology, Department of Laboratory Medicine, Azienda Sanitaria Universitaria Friuli Centrale and University of Udine, Department of Medicine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartor</LastName><ForeName>Assunta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pathology, Department of Laboratory Medicine, Azienda Sanitaria Universitaria Friuli Centrale and University of Udine, Department of Medicine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isola</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Medical Statistics, Department of Medicine, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tascini</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Clin Microbiol Infect. 2022 Oct;28(10):1396. doi: 10.1016/j.cmi.2022.04.007</RefSource><PMID Version="1">35462000</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">Hybrid immunity</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Natural immunity</Keyword><Keyword MajorTopicYN="N">Post&#x2013;COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 antibodies</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 serology</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 vaccination</Keyword><Keyword MajorTopicYN="N">Unvaccinated</Keyword><Keyword MajorTopicYN="N">Vaccinated</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>27</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35339673</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pii">S1198-743X(22)00155-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adeloye D., Elneima O., Daines L., Poinasamy K., Quint J.K., Walker S., et al. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir Med. 2021;9:1467&#x2013;1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8372501</ArticleId><ArticleId IdType="pubmed">34416191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9:747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. 2022;59:2102245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C., Harris B.H.L., Di Giovannantonio M., Rosadas C., Short C.E., Quinlan R., et al. The association between antibody response to severe acute respiratory syndrome coronavirus 2 infection and post-COVID-19 syndrome in healthcare workers. J&#xa0;Infect Dis. 2021;223:1671&#x2013;1676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989400</ArticleId><ArticleId IdType="pubmed">33675366</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Milne A., Samms E., Stadon L., Maskell N.A., Hamilton F.W. Are vaccines safe in patients with long COVID? A prospective observational study. MedRxiv. 2021 [Epub ahead of print]</Citation></Reference><Reference><Citation>Massey D., Berrent D., Krumholz H. Breakthrough symptomatic COVID-19 infections leading to long COVID: report from long COVID Facebook group poll. MedRxiv. 2021 [Epub ahead of print]</Citation></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Do vaccines protect against long COVID? What the data say. Nature. 2021;599:546&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain W.D., Sherwood O., Banerjee A., van der Togt V., Hishmeh L., Rossman J. The impact of COVID vaccination on symptoms of long COVID. An international survey of people with lived experience of long COVID. Vaccines (Basel) 2022;10:652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers J.H., 3rd, Howard K., Saretsky T., Clifford S., Hoffmann S., Llorens L., et al. Patient-reported outcome assessments as endpoints in studies in infectious diseases. Clin Infect Dis. 2016;63:S52&#x2013;S56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5006216</ArticleId><ArticleId IdType="pubmed">27481954</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 Available at:</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., De Martino M., Fabris M., Palese A., Visintini E., Graziano E., et al. The fall in antibody response to SARS-CoV-2: a longitudinal study of asymptomatic to critically ill patients up to 10 months after recovery. J&#xa0;Clin Microbiol. 2021;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525561</ArticleId><ArticleId IdType="pubmed">34379530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Review  Tool to assess risk of bias in cohort studies. https://methods.cochrane.org/sites/methods.cochrane.org.bias/files/public/uploads/Tool%20to%20Assess%20Risk%20of%20Bias%20in%20Cohort%20Studies.pdf Available at:</Citation></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Wu D., Yan W., Wang X., Zhang X., Ma K., et al. Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China. Clin Infect Dis. 2021 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee S., Vatti N., Chang C. Long-term effects of COVID-19. Mayo Clin Proc. 2022;97:579&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Martillo M.A., Dangayach N.S., Tabacof L., Spielman L.A., Dams-O'Connor K., Chan C.C., et al. Postintensive care syndrome in survivors of critical illness related to coronavirus disease 2019: cohort study from a New York City critical care recovery clinic. Crit Care Med. 2021;49:1427&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pubmed">33769771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergwerk M., Gonen T., Lustig Y., Amit S., Lipsitch M., Cohen C., et al. COVID-19 breakthrough infections in vaccinated health care workers. N&#xa0;Engl J Med. 2021;385:1474&#x2013;1484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362591</ArticleId><ArticleId IdType="pubmed">34320281</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. MedRxiv; 2021. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangge H., Kneihsl M., Schnedl W., Sendlhofer G., Curcio F., Domenis R. Immune responses against SARS-CoV-2&#x2013;questions and experiences. Biomedicines. 2021;9:1342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8533170</ArticleId><ArticleId IdType="pubmed">34680460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerussi V., Peghin M., Palese A., Bressan V., Visintini E., Bontempo G., et al. Vaccine hesitancy among Italian patients recovered from COVID-19 infection towards influenza and SARS-Cov-2 vaccination. Vaccines (Basel) 2021;9:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7922251</ArticleId><ArticleId IdType="pubmed">33670661</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa I.F., Bonifacio L.P., Bellissimo-Rodrigues F., Rocha E.M., Jorge R., Bollela V.R., et al. Ocular findings among patients surviving COVID-19. Sci Rep. 2021;11:11085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155146</ArticleId><ArticleId IdType="pubmed">34040094</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Kelly J.D., Win S., Swaminathan S., Li D., et al. Role of antibodies, inflammatory markers, and echocardiographic findings in post-acute cardiopulmonary symptoms after SARS-CoV-2 infection. JCI Insight. 2022;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9220849</ArticleId><ArticleId IdType="pubmed">35389890</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey D., Berrent D., Akrami A., Assaf G., Davis H., Harris K., et al. MedRxiv; 2021. Change in symptoms and immune response in people with post-acute sequelae of SARS-Cov-2 infection (PASC) after SARS-Cov-2 vaccination. [Epub ahead of print]</Citation></Reference><Reference><Citation>Garcia-Abellan J., Padilla S., Fernandez-Gonzalez M., Garcia J.A., Agullo V., Andreo M., et al. Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J&#xa0;Clin Immunol. 2021;41:1490&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Lin H., Ye B., Zhao M., Zhan J., Dong S., et al. One-year sustained cellular and humoral immunities of COVID-19 convalescents. Clin Infect Dis. 2021 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524303</ArticleId><ArticleId IdType="pubmed">34609506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P.K., Bruiners N., Ukey R., Datta P., Onyuka A., Handler D., et al. MedRxiv; 2021. Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells. [Epub ahead of print]</Citation></Reference><Reference><Citation>Rosadas C., Randell P., Khan M., McClure M.O., Tedder R.S. Testing for responses to the wrong SARS-CoV-2 antigen? Lancet. 2020;396:e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455229</ArticleId><ArticleId IdType="pubmed">32866429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavanaugh A.M., Spicer K.B., Thoroughman D., Glick C., Winter K. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination&#x2013;Kentucky, May&#x2013;June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1081&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360277</ArticleId><ArticleId IdType="pubmed">34383732</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozio C.H., Grannis S.J., Naleway A.L., Ong T.C., Butterfield K.A., DeSilva M.B., et al. Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity&#x2013;Nine states, January&#x2013;September 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1539&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8568091</ArticleId><ArticleId IdType="pubmed">34735425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>